研究单位：[1]Beijing Tongren Hospital, Cmu,Beijing,China,100730[2]The Second Hospital to Hebei Medical University,Shijiazhuang,Hebei,China,050000[3]Cangzhou Center Hospital,Cangzhou,Hebei,China,061000[4]BAODING FIRST CENTER HOSPITAL[5]The No.2 Hospital of Baoding,Baoding,Hebei,China,071051[6]The No.2 People'S Hospital Og Weifang,Weifang,Shandong,China,261041[7]Shandong provincial hospital,Jinan,Shandong,China,250117[8]Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
The primary objective of this study is to assess the effectiveness of intranasal budesonide aqueous spray 256 microgram (mcg)/day for treatment of rhinitis symptoms during times of high airborne pollution.
